glutamic acid has been researched along with methoctramine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartoccini, F; Carminati, P; Castorina, M; Di Cesare, MA; Di Serio, S; Gallo, G; Ghirardi, O; Giorgi, F; Giorgi, L; Minetti, P; Piersanti, G; Tarzia, G; Tinti, MO | 1 |
| Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K | 1 |
| Costa, E; de Erausquin, G; Fohrman, EB; Wojcik, WJ | 1 |
| Bogaert, L; Ebinger, G; Michotte, Y; Smolders, I | 1 |
| Haapalinna, A; Larson, J; Niittykoski, M; Ruotsalainen, S; Sirviö, J | 1 |
| Alzheimer, C; Seeger, T | 1 |
6 other study(ies) available for glutamic acid and methoctramine
| Article | Year |
|---|---|
2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.
Topics: Adenine; Adenosine A2 Receptor Antagonists; Animals; Cell Line; Cricetinae; Cricetulus; Drug Design; Humans; Imidazoles; Male; Models, Molecular; Motor Activity; Purines; Radioligand Assay; Rats; Rats, Inbred F344; Structure-Activity Relationship; Triazoles | 2005 |
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship | 2010 |
Muscarinic m3 receptors and dynamics of intracellular Ca2+ cerebellar granule neurons.
Topics: Animals; Calcium; Carbachol; Cells, Cultured; Cerebellum; Dantrolene; Diamines; Fura-2; Glutamates; Glutamic Acid; Microscopy, Fluorescence; Neurons; Parasympatholytics; Quinuclidines; Rats; Receptors, Glutamate; Receptors, Muscarinic; Terpenes; Thapsigargin; Xanthenes | 1993 |
Muscarinic modulation of striatal dopamine, glutamate, and GABA release, as measured with in vivo microdialysis.
Topics: Animals; Cholinergic Agents; Corpus Striatum; Diamines; Dopamine; gamma-Aminobutyric Acid; Glutamic Acid; Male; Microdialysis; Parasympatholytics; Parasympathomimetics; Pilocarpine; Pirenzepine; Rats; Rats, Wistar; Substantia Nigra | 1997 |
Activation of muscarinic M3-like receptors and beta-adrenoceptors, but not M2-like muscarinic receptors or alpha-adrenoceptors, directly modulates corticostriatal neurotransmission in vitro.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; 6-Cyano-7-nitroquinoxaline-2,3-dione; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic Fibers; Animals; Carbachol; Cerebral Cortex; Cholinergic Fibers; Corpus Striatum; Diamines; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Glutamic Acid; Imidazoles; Isoproterenol; Male; Medetomidine; Mice; Mice, Inbred DBA; Muscarinic Agonists; Muscarinic Antagonists; Phenylephrine; Piperidines; Pirenzepine; Pyrrolidinones; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, AMPA; Receptors, Muscarinic; Scopolamine; Synaptic Transmission | 1999 |
Muscarinic activation of inwardly rectifying K(+) conductance reduces EPSPs in rat hippocampal CA1 pyramidal cells.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Carbachol; Cholinergic Agents; Diamines; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Gallamine Triethiodide; Glutamic Acid; Hippocampus; Muscarinic Antagonists; Nicotinic Antagonists; Organ Culture Techniques; Parasympatholytics; Patch-Clamp Techniques; Pirenzepine; Potassium Channels, Inwardly Rectifying; Pyramidal Cells; Rats; Rats, Wistar; Receptor, Muscarinic M2; Receptors, Muscarinic; Stimulation, Chemical | 2001 |